KU Leuven and the Institut Pasteur of Dakar join forces for local vaccine production in Africa

Because of the large number of different cell types in brain tumors, all of which respond differently to treatment, many patients relapse, and the chances of full recovery are very slim. A new diagnostic test, developed by KU Leuven, indicates from a biopsy whether a treatment can attack all the tumor cells present.

Researchers from the Vrije Universiteit Brussel and the EPFL in Lausanne, Switzerland, have developed a highly efficient method for rapid testing the sensitivity of bacteria to antibiotics. The technique, optical nanomotion detection (ONMD), is extremely fast, precise to a single cell and requires only a traditional microscope equipped with a camera or a mobile phone. "Our technique is not only faster but also simpler and much cheaper than all other existing techniques," says VUB professor Ronnie Willaert.

The University of Luxembourg together with Bradford Deep Space Industry have recently started a partnership collaboration to build an efficient and reliable numerical model for water-based propulsion of microsatellites.

Immunotherapy is a powerful way to treat cancer patients but up till now, it was hard to predict why some patients or cancer types do not benefit from this treatment. Researchers could identify markers which predict a patient's or cancer type's response to immunotherapy. For some cancers, immunotherapy can be integrated into the standard treatment but for others, further research is needed to either alter the immunological environment with cancer vaccines or to develop a new type of immunotherapies that target the tumour in another manner.